Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
Acq. announced
Inv. presentation

Mirum Pharmaceuticals, Inc. (MIRM) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2023 4 Radovich Peter (COO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 1,425 shares @ $25.6466, valued at $36.5k
07/05/2023 4 Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 1,004 shares @ $25.6466, valued at $25.7k
07/05/2023 4 Vig Pamela (Head of Research & Development) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 1,425 shares @ $25.6466, valued at $36.5k
07/05/2023 4 Howe Jolanda (SVP, Global Controller) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 915 shares @ $25.6466, valued at $23.5k
Exercised 1,563 options to buy @ $0
Exercised 1,042 restricted stock units @ $0
07/05/2023 4 Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 5,498 shares @ $25.6466, valued at $141k
06/09/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 14,608 shares @ $29, valued at $423.6k
Exercised 14,608 options to buy @ $2.936, valued at $42.9k
05/19/2023 4 Radovich Peter (COO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 968 shares @ $16.9235, valued at $16.4k
05/19/2023 4 Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 684 shares @ $16.9235, valued at $11.6k
05/19/2023 4 Vig Pamela (Head of Research & Development) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 684 shares @ $16.9235, valued at $11.6k
05/19/2023 4 Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 1,256 shares @ $16.9235, valued at $21.3k
05/04/2023 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 14,608 shares @ $28, valued at $409k
Exercised 14,608 options to buy @ $2.936, valued at $42.9k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Flynn James E (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Sold 13,132 shares @ $25.29, valued at $332.1k
Sold 11,868 shares @ $25.29, valued at $300.1k
Sold 171 shares @ $25.08, valued at $4.3k
Sold 155 shares @ $25.08, valued at $3.9k
Sold 6,909 shares @ $24.47, valued at $169.1k
Sold 6,243 shares @ $24.47, valued at $152.8k
06/06/2022 4 Ramasastry Saira (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 34,000 options to buy @ $23.51, valued at $799.3k
06/06/2022 4 Mathers Edward T (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
06/06/2022 4 GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
06/06/2022 4 Brege Laura (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
06/06/2022 4 Fairey William (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 12,750 options to buy @ $23.51, valued at $299.8k
06/06/2022 4 Brosgart Carol L (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 15,583 options to buy @ $23.51, valued at $366.4k
06/06/2022 4 Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
06/06/2022 4 Heron Patrick J (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
06/06/2022 4 O'Donnell Niall (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $23.51, valued at $399.7k
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 1,454 shares @ $13.566, valued at $19.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy